NECTINIUM-2: A Phase Ib, 2-part, Multicenter, Single-arm, Open label Study to Evaluate the Safety and Efficacy of a Nectin-4 Radiopharmaceutical 225Ac Ac-AKY-1189 in Patients with Previously Treated Locally Advanced or Metastatic Solid Tumors

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT07020117

Study #:
STUDY00162174

Start Date:
Mar 17, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07020117

View Complete Trial Details & Eligibility at ClinicalTrials.gov